Clinical trials

Recherche d’études cliniques

Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.

Réinitialiser

Études cliniques 3370

Étude / NCT ⇅ Molécule ⇅ Maladie ⇅ Phase ⇅ Statut ⇅ Résultat ⇅ Sponsor ⇅ Pays / centres ⇅ Période ⇅ Détail
NCT07632755
ADACT — Validation of a Remediation Method for Memory Impairments Throu…
ADACT — Validation of a Remediati… Alzheimer Non applicable RECRUITING En attente / non publié Centre Hospitalier Universitaire … France · Chu de Saint Etienne, Saint-Etienne, France … 2026-07-15 → 2028-06 Ouvrir
NCT07153848
An Observational Study on Lecanemab Treatment for Early Alzheimer's Dis…
An Observational Study on Lecanem… Alzheimer À vérifier RECRUITING En attente / non publié First Affiliated Hospital of Zhej… China · The First Affiliated Hospital of Zhejiang Uni… 2024-07-01 → 2027-12-31 Ouvrir
NCT03472664
BEAT-AD — Brain Energy for Amyloid Transformation in Alzheimer's Diseas…
BEAT-AD — Brain Energy for Amyloi… Alzheimer Non applicable COMPLETED En attente / non publié Wake Forest University Health Sci… United States · Wake Forest Baptist Medical Center, W… 2018-07-16 → 2024-09-13 Ouvrir
NCT04270474
R2D2 — Reducing Risk of Dementia Through Deprescribing
R2D2 — Reducing Risk of Dementia … Alzheimer Non applicable COMPLETED En attente / non publié Indiana University United States · Community Health Network Foundation, … 2020-07-20 → 2026-07-29 Ouvrir
NCT02008357
A4 — Clinical Trial of Solanezumab for Older Individuals Who May be at …
Solanezumab Alzheimer Phase 3 COMPLETED En attente / non publié Eli Lilly and Company United States, Australia, Canada, Japan · Banner Heal… 2014-02-28 → 2023-06-08 Ouvrir
NCT06295458
Flicker w FOG — Gamma Sensory Flicker for Parkinson's Disease Patients …
David Delight Plus Device Alzheimer Non applicable COMPLETED En attente / non publié Emory University United States · Emory Movement Disorders Center, Atla… 2024-07-08 → 2026-05-04 Ouvrir
NCT04239079
Autoimmune Features of Neurodegenerative Disorders
Autoimmune Features of Neurodegen… Alzheimer À vérifier RECRUITING En attente / non publié Columbia University United States · Columbia University Medical Center, N… 2019-05-01 → 2028-07 Ouvrir
NCT03765918
Study of Pembrolizumab Given Prior to Surgery and in Combination With R…
Pembrolizumab 200 mg Parkinson Phase 3 ACTIVE_NOT_RECRUITING En attente / non publié Merck Sharp & Dohme LLC United States, Argentina, Australia, Austria, Belgium… 2018-12-17 → 2026-11-17 Ouvrir
NCT07567794
GBPDC: Gut-Brain in PD Consortium Master Protocol
GBPDC: Gut-Brain in PD Consortium… Parkinson À vérifier RECRUITING En attente / non publié Duke University United States · Columbia University, New York, United… 2026-07-03 → 2028-12-31 Ouvrir
NCT00001215
Genetic Studies of Lysosomal Storage Disorders
Genetic Studies of Lysosomal Stor… Parkinson À vérifier ENROLLING_BY_INVITATION En attente / non publié National Human Genome Research In… United States · National Institutes of Health Clinica… 1995-03-08 Ouvrir
NCT05913687
AIDP — Automated Imaging Differentiation of Parkinsonism
AIDP — Automated Imaging Differen… Parkinson À vérifier ACTIVE_NOT_RECRUITING En attente / non publié University of Florida United States, Canada · Albany Medical College, Alban… 2021-07-22 → 2027-03-31 Ouvrir
NCT07207122
Effects of Transcranial Focused Ultrasound Stimulation (tFUS) on Neurol…
Gen0Bh Transcranial Focused Ultra… Parkinson Non applicable RECRUITING En attente / non publié Sanmai Technologies PBC dba Sanmai United States · Radial Midtown Manhattan, New York, U… 2025-10-08 → 2026-12 Ouvrir
NCT07640542
PIOSA — Test-retest Trial With [11C]MODAG-005 in PD or MSA and AMHC - P…
[11C]MODAG-005 Parkinson Phase 1 RECRUITING En attente / non publié MODAG GmbH Germany · Radiologische Klinik, Universitätsklinikum … 2026-07-29 → 2027-07 Ouvrir
NCT07284342
ONIROS — A Study to Assess Change in Sleep Disturbances of Adult Partic…
ONIROS — A Study to Assess Change… Parkinson À vérifier RECRUITING En attente / non publié AbbVie Spain · Complejo Hospitalario Universitario de Pontev… 2025-11-17 → 2027-01 Ouvrir
NCT07013214
DUAL-PD-RCT — Rehabilitation With Dual-task Exercises to Improve Balanc…
DUAL-PD-RCT — Rehabilitation With… Parkinson Non applicable COMPLETED En attente / non publié G. d'Annunzio University Italy · Fondazione Paolo Sesto - Centro Adriatico, Pe… 2025-07-07 → 2026-03-31 Ouvrir
NCT05816889
Investigation of Exercise Capacity, Muscle Oxygenation and Physical Act…
Investigation of Exercise Capacit… Parkinson À vérifier COMPLETED En attente / non publié Gazi University Turkey (Türkiye) · Gazi University Faculty of Health … 2023-04-01 → 2024-07-30 Ouvrir
NCT03664609
Deep Brain Stimulation (DBS) Retrospective Outcomes Study
Deep Brain Stimulation Parkinson À vérifier RECRUITING En attente / non publié Boston Scientific Corporation United States, Belgium, France, Germany, Italy, Spain… 2019-03-12 → 2028-12 Ouvrir
NCT07745673
tTIS — Comparative Study of TIS Efficacy Across Different Targets
TIS-STN Parkinson Non applicable RECRUITING En attente / non publié Zhongnan Hospital China · Zhongnan Hospital of Wuhan University, Wuhan,… 2026-06-29 → 2027-12-31 Ouvrir
NCT07195825
A Clinical Study to Evaluate the Safety, and Tolerability of BBM-P002 i…
Injecting BBM-P002 into the bilat… Parkinson Phase 1 RECRUITING En attente / non publié Shanghai Xinzhi BioMed Co., Ltd. China · Ruijin Hospital Affiliated to Shanghai Jiao T… 2025-12-27 → 2031-12-30 Ouvrir
NCT06553625
Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Ner…
Radiofrequency Ablation Parkinson À vérifier RECRUITING En attente / non publié Seoul National University Hospital Germany, United Kingdom · St. Georges Hospital, Londo… 2024-01-29 → 2035-12 Ouvrir
NCT07732907
Risk of Progressive Multifocal Leukoencephalopathy Among Patients With …
Ozanimod SEP À vérifier RECRUITING En attente / non publié Bristol-Myers Squibb United States · Bristol Myers Squibb, Lawrenceville, … 2026-06-04 → 2041-07-31 Ouvrir
NCT05380856
Sacral Neuromodulation for Neurogenic Lower Urinary Tract, Bowel and Se…
Turning ON the neuromodulator SEP Non applicable RECRUITING En attente / non publié Odense University Hospital Denmark · Odense University Hospital, Odense, Denmark 2023-09-26 → 2027-03-01 Ouvrir
NCT07225504
REMASTER — A Study to Evaluate the Efficacy and Safety of Remibrutinib …
Remibrutinib (Blinded) SEP Phase 3 RECRUITING En attente / non publié Novartis Pharmaceuticals United States, Argentina, Australia, Austria, Belgium… 2025-11-11 → 2034-01-02 Ouvrir
NCT06925022
ADVICE Phase 1 — Educational Programs Based on Healthy Habits to Improv…
ADVICE Phase 1 — Educational Prog… SEP Non applicable COMPLETED En attente / non publié Universidad de Almeria Spain · Hospital Universitario Virgen de la Arrixaca,… 2024-12-15 → 2026-06-30 Ouvrir
NCT06864936
Exploration of Novel Imaging Biomarkers on OCT for Ublituximab Treatmen…
Ublituximab SEP Non applicable RECRUITING En attente / non publié TG Therapeutics, Inc. United States · University of Maryland, Baltimore, Ba… 2026-05-01 → 2028-01-30 Ouvrir